ArticleInternational journal of molecular sciences2022

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression.

Nina Kreße et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.